Brian J. Blaser's most recent trade in QuidelOrtho Corporation was a trade of 20,759 Restricted Stock Units done . Disclosure was reported to the exchange on May 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| QuidelOrtho Corporation | Mr. Brian J. Blaser | President and CEO | 15 May 2026 | 20,759 | 20,759 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Mr. Brian J. Blaser | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2026 | 20,759 | 45,901 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Mr. Brian J. Blaser | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.32 per share. | 15 May 2026 | 10,252 | 35,649 (0%) | 0% | 10.3 | 105,801 | Common Stock |
| QuidelOrtho Corporation | Mr. Brian J. Blaser | President and CEO | Purchase of securities on an exchange or from another person at price $ 23.59 per share. | 13 Feb 2026 | 10,540 | 40,073 (0%) | 0% | 23.6 | 248,661 | Common Stock |
| QuidelOrtho Corporation | Mr. Brian J. Blaser | President and CEO | 30 Jan 2026 | 213,470 | 213,470 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Mr. Brian J. Blaser | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 21,446 | 32,897 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Mr. Brian J. Blaser | President and CEO | 29 Jan 2026 | 21,446 | 42,892 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Mr. Brian J. Blaser | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.41 per share. | 29 Jan 2026 | 7,755 | 25,142 (0%) | 0% | 27.4 | 212,565 | Common Stock |
| QuidelOrtho Corporation | Mr. Brian J. Blaser | President and CEO | Purchase of securities on an exchange or from another person at price $ 21.34 per share. | 19 Nov 2025 | 23,500 | 29,533 (0%) | 0% | 21.3 | 501,577 | Common Stock |
| QuidelOrtho Corporation | Mr. Brian J. Blaser | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 20,759 | 20,759 (0%) | 0% | 0 | Common Stock | |
| QuidelOrtho Corporation | Mr. Brian J. Blaser | President and CEO | 15 May 2025 | 20,759 | 41,518 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Mr. Brian J. Blaser | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.03 per share. | 15 May 2025 | 9,308 | 11,451 (0%) | 0% | 33.0 | 307,443 | Common Stock |
| QuidelOrtho Corporation | Mr. Brian J. Blaser | President and CEO | 29 Jan 2025 | 64,338 | 64,338 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Mr. Brian J. Blaser | President and CEO | 29 Jan 2025 | 52,390 | 52,390 | - | - | Restricted Stock Units | ||
| QuidelOrtho Corporation | Mr. Brian J. Blaser | President and CEO | Purchase of securities on an exchange or from another person at price $ 41.42 per share. | 11 Dec 2024 | 6,033 | 6,033 (0%) | 0% | 41.4 | 249,878 | Common Stock |
| Quanterix Corp | Mr. Brian J. Blaser | Director | 02 Jan 2024 | 6,412 | 6,412 | - | - | Stock Option (Right to Buy) | ||
| Quanterix Corp | Mr. Brian J. Blaser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 2,947 | 19,049 (0%) | 0% | 0 | Common Stock | |
| Quanterix Corp | Mr. Brian J. Blaser | Director | 06 Jan 2023 | 24,153 | 24,153 | - | - | Stock Option (right to buy) | ||
| Quanterix Corp | Mr. Brian J. Blaser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 16,102 | 16,102 (0%) | 0% | 0 | Common Stock |